Interventional device developers Boston Scientific of Natick, MA, and Abbott Laboratories of Abbott Park, IL, reported that they have received antitrust clearance from the U.S. Federal Trade Commission (FTC) for their proposed acquisition of Indianapolis-based Guidant.
Boston Scientific and Abbott said that the FTC has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
Boston Scientific, Abbott, and Guidant intend to close the transaction on April 21.
By AuntMinnie.com staff writers
April 20, 2006
Related Reading
Boston Scientific sets Q1 sales record, April 18, 2006
Boston Scientific, Abbott get EC approval for Guidant deal, April 12, 2006
Boston Scientific resolves Guidant antitrust issues, April 6, 2006
Boston Scientific, Guidant deal gets shareholder nod, April 3, 2006
Boston Scientific submits final Liberté PMA module, March 9, 2006
Copyright © 2006 AuntMinnie.com
